Evidence map›Paper›PMID 35286712›Full record

ReviewJournal of the experimental analysis of behavior2022

Cholinergic and dopaminergic-mediated motivated behavior in healthy states and in substance use and mood disorders.

Eric J Nunes, Nardos Kebede, Deniz Bagdas, Nii A Addy

Open access · greenAbstract readReview
In one paragraph

Review in Journal of the experimental analysis of behavior, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.6field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 18 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Exergaming and Cognitive Function Research: A Bibliometric Visualization Analysis Using CiteSpace.Inquiry : a journal of medical care organization, provision and financing
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Eric J NunesDepartment of Psychiatry, Yale School of Medicine.
Nardos KebedeDepartment of Psychiatry, Yale School of Medicine.
Deniz BagdasDepartment of Psychiatry, Yale School of Medicine.
Nii A AddyDepartment of Psychiatry, Yale School of Medicine.
Yale University · US

Funding

Yale Center for the Study of Tobacco Product Use and Addiction (YCSTP) Project 2: Addictive Threshold of Nicotine and the Impact of SweetenersU54DA036151 · NIDA · YALE UNIVERSITY · PI TORE EID · 2018 to 2026
$41.6M
L-Type Calcium Channel Mechanisms Mediating Comorbid Substance Use and Mood DisordersR01DA050454 · NIDA · YALE UNIVERSITY · PI ADDY, NII A · 2020 to 2024
$2.0M
Ventral Tegmental Area Cholinergic Mechanisms Mediating Susceptibility to StressR01MH108663 · NIMH · YALE UNIVERSITY · PI ADDY, NII A · 2016 to 2019
$1.7M
NIDA NIH HHS R01 DA050454NIDA NIH HHS U54 DA036151NIDA NIH HHS U54 DA0361519NIMH NIH HHS MH108663
6 · The paper itself

Abstract

Acetylcholine is an important neuromodulator of the mesolimbic dopamine (DA) system, which itself is a mediator of motivated behavior. Motivated behavior can be described by two primary components, termed directional and activational motivation, both of which can be examined and dissociated using effort-choice tasks. The directional component refers to motivated behavior directed towards reinforcing stimuli and away from aversive stimuli. Behaviors characterized by increased vigor, persistence, and work output are considered to reflect activational components of motivation. Disruption of DA signaling has been shown to decrease activational components of motivation, while leaving directional features intact. Facilitation of DA release promotes the activational aspects of motivated behavior. In this review, we discuss cholinergic and DA regulation of motivated behaviors. We place emphasis on effort-choice processes and the ability of effort-choice tasks to examine and dissociate changes of motivated behavior in the context of substance use and mood disorders. Furthermore, we consider how altered cholinergic transmission impacts motivated behavior across disease states, and the possible role of cholinergic dysregulation in the etiology of these illnesses. Finally, we suggest that treatments targeting cholinergic activity may be useful in ameliorating motivational disruptions associated with substance use and comorbid substance use and mood disorders.

Indexed as

DopamineSubstance-Related DisordersCholinergic AgentsHumansMood DisordersMotivationNucleus AccumbensCholinergic AgentsDopamineacetylcholinedepressiondopaminemotivationsubstance use

Identifiers

PMID35286712
PMCPMC9743782
OpenAlexW4220752054

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.